100 related articles for article (PubMed ID: 1378901)
1. The discovery of (2S,3S)-cis-2-(diphenylmethyl)-N-[(2-methoxyphenyl)methyl]-1- azabicyclo[2.2.2]-octan-3-amine as a novel, nonpeptide substance P antagonisst.
Lowe JA; Drozda SE; Snider RM; Longo KP; Zorn SH; Morrone J; Jackson ER; McLean S; Bryce DK; Bordner J
J Med Chem; 1992 Jul; 35(14):2591-600. PubMed ID: 1378901
[TBL] [Abstract][Full Text] [Related]
2. A potent nonpeptide antagonist of the substance P (NK1) receptor.
Snider RM; Constantine JW; Lowe JA; Longo KP; Lebel WS; Woody HA; Drozda SE; Desai MC; Vinick FJ; Spencer RW
Science; 1991 Jan; 251(4992):435-7. PubMed ID: 1703323
[TBL] [Abstract][Full Text] [Related]
3. A selective and potent antagonist of substance P receptors on pancreatic acinar cells.
Sjödin L; Gylfe E
Biochem Int; 1992 Jun; 27(1):145-53. PubMed ID: 1378274
[TBL] [Abstract][Full Text] [Related]
4. Effect of CP-96,345, a nonpeptide substance P receptor antagonist, on salivation in rats.
Snider RM; Longo KP; Drozda SE; Lowe JA; Leeman SE
Proc Natl Acad Sci U S A; 1991 Nov; 88(22):10042-4. PubMed ID: 1719543
[TBL] [Abstract][Full Text] [Related]
5. CP-96,345, a non-peptide antagonist of substance P: II. Actions on substance P-induced hypotension and bronchoconstriction, and on depressor reflexes in mammals.
Griesbacher T; Donnerer J; Legat FJ; Lembeck F
Naunyn Schmiedebergs Arch Pharmacol; 1992 Sep; 346(3):323-7. PubMed ID: 1383835
[TBL] [Abstract][Full Text] [Related]
6. CP-96,345, which inhibits [3H] substance P binding, selectively inhibits the behavioral response to intrathecally administered N-methyl-D-aspartate, but not substance P, in the mouse.
Velázquez RA; Kitto KF; Larson AA
J Pharmacol Exp Ther; 1997 Jun; 281(3):1231-7. PubMed ID: 9190858
[TBL] [Abstract][Full Text] [Related]
7. Analysis of a nonpeptide antagonist for substance P on myenteric neurons of guinea-pig small intestine.
Tamura K; Mutabagani K; Wood JD
Eur J Pharmacol; 1993 Mar; 232(2-3):235-9. PubMed ID: 7682179
[TBL] [Abstract][Full Text] [Related]
8. Photoaffinity labeling of the human substance P (neurokinin-1) receptor with [3H2]azido-CP-96,345, a photoreactive derivative of a nonpeptide antagonist.
MacDonald D; Silberman SC; Lowe JA; Drozda SE; Leeman SE; Boyd ND
Mol Pharmacol; 1996 May; 49(5):808-13. PubMed ID: 8622630
[TBL] [Abstract][Full Text] [Related]
9. Substance P-induced mitogenesis in human astrocytoma cells correlates with activation of the mitogen-activated protein kinase signaling pathway.
Luo W; Sharif TR; Sharif M
Cancer Res; 1996 Nov; 56(21):4983-91. PubMed ID: 8895754
[TBL] [Abstract][Full Text] [Related]
10. Role of NK-1 receptor in central cardiovascular regulation in rats: studies on a novel non-peptide antagonist, CP-96,345, of substance P NK-1 receptor.
Takano Y; Nakayama Y; Tateishi K; Saito R; Kamiya H
Neurosci Lett; 1992 May; 139(1):122-5. PubMed ID: 1328962
[TBL] [Abstract][Full Text] [Related]
11. Neurokinin-1 receptor antagonists CP-96,345 and L-733,060 protect mice from cytokine-mediated liver injury.
Bang R; Sass G; Kiemer AK; Vollmar AM; Neuhuber WL; Tiegs G
J Pharmacol Exp Ther; 2003 Apr; 305(1):31-9. PubMed ID: 12649350
[TBL] [Abstract][Full Text] [Related]
12. SR 48968 specifically depresses neurokinin A- vs. substance P-induced hyperalgesia in a nociceptive withdrawal reflex.
Yashpal K; Hui-Chan CW; Henry JL
Eur J Pharmacol; 1996 Jul; 308(1):41-8. PubMed ID: 8836630
[TBL] [Abstract][Full Text] [Related]
13. FK 224, a novel cyclopeptide substance P antagonist with NK1 and NK2 receptor selectivity.
Morimoto H; Murai M; Maeda Y; Yamaoka M; Nishikawa M; Kiyotoh S; Fujii T
J Pharmacol Exp Ther; 1992 Jul; 262(1):398-402. PubMed ID: 1378096
[TBL] [Abstract][Full Text] [Related]
14. Antibronchospastic activity of MEN10,627, a novel tachykinin NK2 receptor antagonist, in guinea-pig airways.
Perretti F; Ballati L; Manzini S; Maggi CA; Evangelista S
Eur J Pharmacol; 1995 Jan; 273(1-2):129-35. PubMed ID: 7737306
[TBL] [Abstract][Full Text] [Related]
15. Characterization of CP-122,721; a nonpeptide antagonist of the neurokinin NK1 receptor.
McLean S; Ganong A; Seymour PA; Bryce DK; Crawford RT; Morrone J; Reynolds LS; Schmidt AW; Zorn S; Watson J; Fossa A; DePasquale M; Rosen T; Nagahisa A; Tsuchiya M; Heym J
J Pharmacol Exp Ther; 1996 May; 277(2):900-8. PubMed ID: 8627572
[TBL] [Abstract][Full Text] [Related]
16. The pharmacology of GR203040, a novel, potent and selective non-peptide tachykinin NK1 receptor antagonist.
Beattie DT; Beresford IJ; Connor HE; Marshall FH; Hawcock AB; Hagan RM; Bowers J; Birch PJ; Ward P
Br J Pharmacol; 1995 Dec; 116(8):3149-57. PubMed ID: 8719789
[TBL] [Abstract][Full Text] [Related]
17. Comparison of antagonistic effects of sendide and CP-96,345 on a spinally mediated behavioural response in mice.
Sakurada T; Manome Y; Katsumata K; Tan-No K; Sakurada S; Ohba M; Kisara K
Eur J Pharmacol; 1994 Aug; 261(1-2):85-90. PubMed ID: 7528145
[TBL] [Abstract][Full Text] [Related]
18. Anti-emetic activity of the novel nonpeptide tachykinin NK1 receptor antagonist ezlopitant (CJ-11,974) against acute and delayed cisplatin-induced emesis in the ferret.
Tsuchiya M; Fujiwara Y; Kanai Y; Mizutani M; Shimada K; Suga O; Ueda S; Watson JW; Nagahisa A
Pharmacology; 2002 Nov; 66(3):144-52. PubMed ID: 12372904
[TBL] [Abstract][Full Text] [Related]
19. Dopamine D1 receptor-stimulated release of acetylcholine in rat striatum is mediated indirectly by activation of striatal neurokinin1 receptors.
Anderson JJ; Kuo S; Chase TN; Engber TM
J Pharmacol Exp Ther; 1994 Jun; 269(3):1144-51. PubMed ID: 7912277
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological evidence that neuropeptides mediate part of the actions of scorpion venom on the guinea pig ileum.
Matos IM; Teixeira MM; Leite R; Freire-Maia L
Eur J Pharmacol; 1999 Mar; 368(2-3):231-6. PubMed ID: 10193659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
